PT-141 (bremelanotide) is a cyclic melanocortin analog research peptide focused on MC4R activation, studied in central melanocortin signaling and receptor pathway research.
PT-141, known in literature as bremelanotide, is a cyclic melanocortin research peptide derived from Melanotan 2. It is studied primarily for its activation of the melanocortin-4 receptor (MC4R), a centrally expressed receptor involved in a range of signaling cascades, and serves as a key probe in CNS melanocortin pathway research.
Research Applications
Handling & Storage
Supplied as a lyophilized powder. Store sealed vials in a cool, dry place away from light; refrigerate after reconstitution with bacteriostatic water and avoid repeated freeze-thaw cycles.
This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch of PT-141 is independently tested for identity and purity, and ships with its own Certificate of Analysis — lot information included, where a researcher can actually find it.
View Testing Documentation →Batch COA provided with every order.
A curated list of published, peer-reviewed papers indexed in PubMed where PT-141 has been studied. Provided for research context only — linking to the literature does not constitute endorsement of any therapeutic application.
PT-141 (bremelanotide) is a cyclic melanocortin analog research peptide focused on MC4R activation, studied in central melanocortin signaling and receptor pathway research. This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 4PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
